Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication.

Antiviral research - 1 Jan 2008

Korba Brent E, Montero Abigail B, Farrar Kristine, Gaye Karen, Mukerjee Sampa, Ayers Marc S, Rossignol Jean-François

Abstract excerpt

Nitazoxanide (NTZ), a thiazolide anti-infective, is active against anaerobic bacteria, protozoa, and a range of viruses in cell culture models, and is currently in phase II clinical development for treating chronic hepatitis C. In this report, we characterize the activities of NTZ and its active metabolite, tizoxanide (TIZ), along with other thiazolides against hepatitis B virus (HBV) and hepatitis C virus (HCV)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis B virus

Share to Nitro Compounds

Share to Thiazoles

Share to Virus Replication

Source

Identifiers

PMID: 17888524
DOI: 10.1016/j.antiviral.2007.08.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication.PMID 17888524Read ↗

Short Communication: Nitazoxanide Inhibits HIV Viral Replication in Monocyte-Derived MacrophagesSemantic proximity Read ↗

Discovery of imidazo[2,1-b]thiazole HCV NS4B inhibitors exhibiting synergistic effect with other direct-acting antiviral agents.Semantic proximity Read ↗

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4.Semantic proximity Read ↗

Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine.Semantic proximity Read ↗

Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.Semantic proximity Read ↗

Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.Semantic proximity Read ↗

Assessment of the activity of directly acting antivirals and other products against different genotypes of hepatitis C virus prevalent in resource-poor countries.Semantic proximity Read ↗

2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus with a Novel Mechanism of Action.Semantic proximity Read ↗

Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems.Semantic proximity Read ↗

Potential for Hepatitis C Virus Resistance to Nitazoxanide or TizoxanideSemantic proximity Read ↗

Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions.Semantic proximity Read ↗

Thiazolides, a New Class of Antiviral Agents Effective against Rotavirus Infection, Target Viral Morphogenesis, Inhibiting Viroplasm FormationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.